Annual report pursuant to Section 13 and 15(d)

Accrued Expenses - Schedule of Accrued Expenses (Details)

v3.24.1
Accrued Expenses - Schedule of Accrued Expenses (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Accrued Liabilities, Current [Abstract]    
External research and preclinical development $ 8,001 $ 8,219
Employee compensation and benefits 6,993 8,529
Professional fees 1,015 1,164
Facilities and other 137 54
Accrued expenses $ 16,146 $ 17,966